CCR2 and myeloid sarcoma: Given the evidence that CCR2 is expressed on microglia and macrophages in chronic active MS lesions and on perivascular mononuclear cells in both white matter lesions and unaffected cortex, CCX872 presents a particularly promising candidate for further investigation in MS.